Capital Fund Management S.A. Organon & Co. Put Options Transaction History

Capital Fund Management S.A.

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	SELL	$18.65 - $23.03 $212,609 - $262,542	-11,400 Reduced 13.07%	75,800 $1.45 Million
Q2 2024 Aug 13, 2024	SELL	$17.45 - $21.96 $4.62 Million - $5.82 Million	-264,800 Reduced 75.23%	87,200 $1.81 Million
Q1 2024 May 15, 2024	BUY	$13.78 - $18.8 $1.17 Million - $1.6 Million	85,000 Added 31.84%	352,000 $6.62 Million
Q4 2023 Feb 14, 2024	BUY	$10.95 - $17.32 $519,029 - $820,968	47,400 Added 21.58%	267,000 $3.85 Million
Q3 2023 Nov 14, 2023	BUY	$16.59 - $23.77 $1.6 Million - $2.3 Million	96,700 Added 78.68%	219,600 $3.81 Million
Q2 2023 Aug 14, 2023	BUY	$19.27 - $24.63 $2.37 Million - $3.03 Million	122,900 New	122,900 $2.56 Million

795

204M

1.71M

870K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.